Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis.

MLA

Valencia, Tania, et al. “Metabolic Reprogramming of Stromal Fibroblasts through P62-MTORC1 Signaling Promotes Inflammation and Tumorigenesis.” Cancer Cell, vol. 26, no. 1, July 2014, pp. 121–35. EBSCOhost, https://doi.org/10.1016/j.ccr.2014.05.004.

APA

Valencia, T., Kim, J. Y., Abu-Baker, S., Moscat-Pardos, J., Ahn, C. S., Reina-Campos, M., Duran, A., Castilla, E. A., Metallo, C. M., Diaz-Meco, M. T., & Moscat, J. (2014). Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis. Cancer Cell, 26(1), 121–135. https://doi.org/10.1016/j.ccr.2014.05.004

Chicago

Valencia, Tania, Ji Young Kim, Shadi Abu-Baker, Jorge Moscat-Pardos, Christopher S Ahn, Miguel Reina-Campos, Angeles Duran, et al. 2014. “Metabolic Reprogramming of Stromal Fibroblasts through P62-MTORC1 Signaling Promotes Inflammation and Tumorigenesis.” Cancer Cell 26 (1): 121–35. doi:10.1016/j.ccr.2014.05.004.